Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) EBT (2016 - 2025)

Bruker (BRKR) has disclosed EBT for 16 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 101.52% year-over-year to $6.1 million, compared with a TTM value of -$41.7 million through Dec 2025, up 83.33%, and an annual FY2025 reading of $339.9 million, up 235.85% over the prior year.
  • EBT was $6.1 million for Q4 2025 at Bruker, up from -$71.8 million in the prior quarter.
  • Across five years, EBT topped out at $240.2 million in Q4 2023 and bottomed at -$401.0 million in Q4 2024.
  • Average EBT over 5 years is $11.1 million, with a median of $70.6 million recorded in 2022.
  • The sharpest move saw EBT skyrocketed 531.85% in 2021, then crashed 266.94% in 2024.
  • Year by year, EBT stood at -$289.5 million in 2021, then fell by 5.77% to -$306.2 million in 2022, then soared by 178.45% to $240.2 million in 2023, then plummeted by 266.94% to -$401.0 million in 2024, then surged by 101.52% to $6.1 million in 2025.
  • Business Quant data shows EBT for BRKR at $6.1 million in Q4 2025, -$71.8 million in Q3 2025, and -$1.1 million in Q2 2025.